STĘŻENIE DIALDEHYDU MALONOWEGO WE KRWI JAKO WSKAŹNIK PRZY PRZESZCZEPIE WĄTROBY

Jadwiga Piwowarska; Jolanta Felczak; Jacek Łukaszkiewicz

doi:10.56782/pps.113

Published : 2016-11-02

Vol. 14 No. 6 (2016)

CONCENTRATION OF MALONDIALDEHYDE IN BLOOD AS AN INDICATOR IN LIVER TRANSPLANTATION

Jadwiga Piwowarska

Jolanta Felczak

Jacek Łukaszkiewicz

DOI: https://doi.org/10.56782/pps.113

Abstract

Liver transplants and tumors are associated with oxidative stress and its biological marker malondialdehyde (MDA), a product of lipid peroxidation. The aim of the study was to determine whether the level of MDA in the donor is useful as a prognostic marker of graft survival following transplantation. Using HPLC-UV, the concentration of free MDA was determined in blood serum of 20 transplant recipients suffering from hepatocellular carcinoma, and 20 donors prior to transplantation. Validation of the analytical method demonstrated its usefulness in the determination of free MDA concentration in blood serum. The measured MDA concentrations varied within either group, with a range of 0–48 µmol/L in recipients and 0–3.54 µmol/L in donors. Because of the low number of patients in both groups, the results are inconclusive with regard to possible differences between donors and recipients, even though the mean values were lower in donors than in recipients. Therefore, further studies are needed to decide whether the determination of MDA concentrations in donors constitutes a useful prognostic indicator of graft survival following liver transplantation.

Keywords:

MDA, HPLC, oxidative stress, liver transplantation, cancer hepatocellular carcinoma

Most read articles by the same author(s)

Marcin Łukasik, Jolanta Karmalska, Mirosław M. Szutowski, Jacek Łukaszkiewicz, EFFECT OF DNA METHYLATION ON GENOME FUNCTION , Prospects in Pharmaceutical Sciences: Vol. 7 No. 2 (2009)
Grażyna Kubiak-Tomaszewska, Jan Pachecka, Jacek Łukaszkiewicz, Piotr Tomaszewski, MECHANISMS OF RECEPTOR-DEPENDENT REGULATION OF BILE ACID AND XENOBIOTIC METABOLISM. THE ROLE OF CYP3A4 EXPRESSION IN THE SAFETY AND EFFECTIVENESS OF PHARMACOTHERAPY , Prospects in Pharmaceutical Sciences: Vol. 14 No. 9 (2016)

Similar Articles

Andrzej Tokarz, Małgorzata Jelińska, Agnieszka Ozga, ISOPROSTANES - NEW BIOMARKERS IN LIPID PEROXIDATION IN VIVO , Prospects in Pharmaceutical Sciences: Vol. 2 No. 2 (2004)
Nazan Çömlekçioğlu, Nuh Korkmaz, Mehmet Ali Yüzbaşıoğlu, İmran Uysal, Mustafa Sevindik, Mistletoe (Loranthus europaeus Jacq.): antioxidant, antimicrobial and anticholinesterase activities , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Magdalena Bamburowicz-Klimkowska, Mirosław M. Szutowski, STRATEGIES TO COMBAT MULTIDRUG RESISTANCE OF CANCER , Prospects in Pharmaceutical Sciences: Vol. 10 No. 1 (2012)
Natalia Korytowska, Beata Pytlak, Mariusz Niemczyk, CHRONIC KIDNEY DISEASE AND SELECTED ASPECTS OF KIDNEY RECIPIENTS MONITORING , Prospects in Pharmaceutical Sciences: Vol. 18 No. 4 (2020)
Paweł Żero, Maria Niemyjska, Magdalena Rasztawicka, Dorota Maciejewska, BREAST CANCER DISEASE AND NEW COMPOUNDS WITH ANTICANCER ACTIVITY , Prospects in Pharmaceutical Sciences: Vol. 3 No. 2 (2005)
Saffalya Nayak, Pratima Kumari Sahu, Roma Rattan, Srikrushna Mahapatra, Debjyoti Mohapatra, Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Magdalena Tchorzewska, Malwina Kowalik, Adrianna Kuliś, Wioletta Olejarz, MECHANISMS LEADING TO ANGIOGEGNESIS IN CANCERS , Prospects in Pharmaceutical Sciences: Vol. 17 No. 10 (2019)
Mateusz Żaczko, Tomasz Lorenc, Wioletta Olejarz, Grażyna Nowicka, PERSPECTIVES OF THERAPEUTIC USE OF EXOSOMES IN THE MOST COMMON CANCERS , Prospects in Pharmaceutical Sciences: Vol. 17 No. 6 (2019)
Justyna Śledź, ORAL CAVITY CANCER - EPIDEMIOLOGICAL DATA AND RISK FACTORS , Prospects in Pharmaceutical Sciences: Vol. 13 No. 2 (2015)
Emilia Balcer, Maciej Mazur, GOLD NANOPARTICLES IN THE DIAGNOSTICS AND THERAPY OF CANCER – CHOSEN APPLICATIONS , Prospects in Pharmaceutical Sciences: Vol. 18 No. 1 (2020)

<< < 1 2 3 4 5 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Piwowarska, J., Felczak, J., & Łukaszkiewicz, J. (2016). CONCENTRATION OF MALONDIALDEHYDE IN BLOOD AS AN INDICATOR IN LIVER TRANSPLANTATION. Prospects in Pharmaceutical Sciences, 14(6), 40–44. https://doi.org/10.56782/pps.113

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

. Polański J., Bardadin K.: Biblioteka po Dyplomie. Hepatologia: kompendium. Medical Tribune Group 2004.

Zhang W., Wang M., Xie H.Y., Zhou L., Meng X.Q., Shi J., Zheng S.: Role of Reactive Oxygen Species in Mediating Hepatic Ischemia-Reperfusion Injury. Transplant Proc 2007, 39, 1332-1337. DOI: https://doi.org/10.1016/j.transproceed.2006.11.021

Del Rio D., Stewart A.J., Pellegrini N.: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases 2005, 15(4), 316-328. DOI: https://doi.org/10.1016/j.numecd.2005.05.003

Gaweł S., Wardas M., Niedworok E., Wardas P.: Dialdehyd malonowy (MDA) jako wskaźnik procesów peroksydacji lipidów w organizmie. Wiad Lek 2004, 57(9-10), 453-45.

Kosieradzki M., Kuczynska J., Piwowarska J., Wegrowicz-Rebandel I., Kwiatkowski A., Lisik W., Michalak G., Danielewicz R., Paczek L., Rowinski W.: Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation 2003, 75(8), 1221-1227. DOI: https://doi.org/10.1097/01.TP.0000065282.46425.87

Rowiński W., Wałaszewski J., Pączek L.: Transplantologia kliniczna. PZWL, Warszawa 2004.

Długosz A., Średnicka D., Boratyński J.: Wpływ takrolimusu na stres oksydacyjny i procesy wolnorodnikowe. Postępy Hig Med Dośw 2007, 61, 466-471.

Brodsky SV, Yamamoto T, Tada T, et al.: Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282(6), 1140-1149 DOI: https://doi.org/10.1152/ajprenal.00329.2001

Li C, Jackson RM.: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282 (2), 227-241. DOI: https://doi.org/10.1152/ajpcell.00112.2001

Bartosz G.: Druga twarz tlenu. Wolne rodniki w przyrodzie. Wydawnictwo Naukowe PWN, Warszawa 2006.

Niedernhofer LJ, Daniels JS, Rouzer CA.: Malondialdrhyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 2003, 278, 31426-33. DOI: https://doi.org/10.1074/jbc.M212549200

Uchida K.: Role of reactive aldehyde in cardiovascular disease. Int J Biochem Cell Biol 2000, 28, 1685-96. DOI: https://doi.org/10.1016/S0891-5849(00)00226-4

Wilson D., Metz H., Graver L., Rao P.S.: Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples. Clin Chem 1997, 43(10), 1982-1983. DOI: https://doi.org/10.1093/clinchem/43.10.1982

Steghens JP., van Kappel AL., Denis I., Collombel C.: Diaminonaphtalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. Free Radic Biol Med. 2001, 31(2), 242-249. DOI: https://doi.org/10.1016/S0891-5849(01)00578-0

Carbonneau MA., Peuchant E., Sess D.: Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma. Clin Chem 1991, 37, 1423-1429. DOI: https://doi.org/10.1093/clinchem/37.8.1423

Yeo HC., Helbock HJ., Chyu D.: Assay of malondialdehyde in biological fluids by gas chromatography – mass spectrometry. Anal Biochem 1994, 220, 391-396. DOI: https://doi.org/10.1006/abio.1994.1355

Mao J., Zhang H., Luo J.: New method for HPLC separation and fluorescence detection of malonaldehyde in normal human plasma. J Chromatogr B 2006, 832, 103-108. DOI: https://doi.org/10.1016/j.jchromb.2005.12.041

Hong YL., Yeh SL., Chang CY., Hu ML.: Total plasma malondialdehyde levels in 16 Taiwanese college students determined by various thiobarbituric acid tests and an improved high-performance liquid chromatography-based method. Clin Biochem. 2000, 33(8), 619-625. DOI: https://doi.org/10.1016/S0009-9120(00)00177-6

Pilz J., Meineke I., Gleiter Ch.H.: Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B 2000, 742, 315-325. DOI: https://doi.org/10.1016/S0378-4347(00)00174-2

Largilliere C., Melancon SB.: Free Malondialdehyde determination in human plasma by High-Performance Liquid Chromatography. Anal Biochem 1988, 170(1), 123-126. DOI: https://doi.org/10.1016/0003-2697(88)90098-X

Bartosz G.: Druga twarz tlenu. Wolne rodniki w przyrodzie, Wydawnictwo Naukowe PWN, Warszawa 2006.

Zhao J., Zhao Y., Wang H., Gu X., Ji J., Gao C.: Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study. Nutr J 2011, 10, 49-56. DOI: https://doi.org/10.1186/1475-2891-10-49

Tsai S.M., Lin S.K., Lee K.T., Hsiao J.K., Huang J.C., Wu S.H., Ma H., Wu S.H., Tsai L.Y.: Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. Ann Clin Biochem 2009, 46, 394-400. DOI: https://doi.org/10.1258/acb.2009.009029

Czeczot H., Scibior D., Skrzycki M., Podsiad M.: Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol 2006, 53, 237-242. DOI: https://doi.org/10.18388/abp.2006_3384

Lorente L, Rodriguez ST, Sanz P, Abreu-González P, Díaz D, Moreno AM, Borja E, Martín MM, Jiménez A, Barrera MA.: Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma. Int J Mol Sci 2016, 17, 1-10. DOI: https://doi.org/10.3390/ijms17040500

Pilaszek Z.: Wpływ zmian nowotworowych w wątrobie na efektywność ektogenezy. Praca magisterska, Warszawski Uniwersytet Medyczny, Warszawa, 2008.

Jadwiga Piwowarska

adwiga.piwowarska@wum.edu.pl

Affiliation:

Katedra i Zakład Biochemii i Chemii Klinicznej, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej, Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland

Bio Statement (e.g., department and rank)

autorka korespondująca, tel: +48 22 5720 737

Jolanta Felczak

Affiliation:

Katedra i Zakład Biochemii i Chemii Klinicznej, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej, Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland

Jacek Łukaszkiewicz

Affiliation:

Katedra i Zakład Biochemii i Chemii Klinicznej, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej, Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland